AVEO Oncology
AVEO
#7099
Rank
โ‚น46.84 B
Marketcap
โ‚น1,348
Share price
0.00%
Change (1 day)
187.23%
Change (1 year)

Revenue for AVEO Oncology (AVEO)

Revenue in 2022 (TTM): โ‚น7.37 Billion

According to AVEO Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚น8.47 Billion. In 2021 the company made a revenue of โ‚น3.14 Billion an increase over the revenue in the year 2020 that were of โ‚น0.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AVEO Oncology from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น7.37 B134.36%
2021 โ‚น3.14 B615.16%
2020 โ‚น0.44 B-78.56%
2019 โ‚น2.05 B442.92%
2018 โ‚น0.37 B-21.85%
2017 โ‚น0.48 B183.15%
2016 โ‚น0.17 B-86.48%
2015 โ‚น1.26 B10.06%
2014 โ‚น1.14 B1337.96%
2013 โ‚น79.88 M-92.44%
2012 โ‚น1.05 B-87.89%
2011 โ‚น8.72 B335.55%
2010 โ‚น2.00 B108.27%
2009 โ‚น0.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
โ‚น904.28 B 10,572.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น1.279 T 15,005.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 50,827.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น5.338 T 62,898.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.231 T 38,037.60%๐Ÿ‡บ๐Ÿ‡ธ USA